Answers are grounded in this paper and cite their sources.
Rationale. Hematopoietic stem cell transplantation (HSCT) providing possibility to cure malignant oncohematological diseases, selected solid tumors and autoimmune disorders. Aim of review is summarizing of major data on development and perspective of HSCT, studying of new possibilities and developing alternative technologies improving effectiveness of anti-leukemia potential of allogenic HSCT (allo-HSCT) and, at the same time, decreasing of risk of severe complications. General statues. Allo-HSCT as a method of immunotherapy contributes prolonged remissions, but still limited transplant related morbidity and mortality due to toxic effects on body, infection complications and “graft-versus-host” disease (GvHD). Different methods decreasing side effects of HSCT have been developed. One of the major recent achievements are the successes in haploidentical transplants, which based on the new approaches of GvHD prophylaxis and became accessible almost for all suitable patients and do not concede of standard alloHSCT on efficacy and safety. Allo-HSCT after reduced intensity conditioning or non-myeloablative conditioning for treatment of elderly or weakened patients with advanced stages of hematological malignant disorders have successfully implemented. It was shown how the new technologies enhancing effectiveness of anti-tumor potential allo-HSCT and simultaneously decreases the risks of severe complications. Own experience of allo-HSCT at 19 patients presented. It was shown in our study that allo-HSCT did not improved outcome for refractory/ relapsing patients with acute leukemias, but can be successfully used in remission phase. Conclusion. Role of stem cells in treatment of haematological and non-hematological malignant diseases (as well as some autoimmune disorders) continuously growing. Comprehensive knowledge on possibilities of usage of transplant technologies, modern methods of cell therapy of leukemias allows to decrease drug toxicity and improve the patients’ outcomes.
No takes yet. Share an insight, caveat, or question.
Pop et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: